SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000818686-10-000086
Filing Date
2010-08-04
Accepted
2010-08-04 07:27:31
Documents
3
Period of Report
2009-04-01

Document Format Files

Seq Description Document Type Size
1 TEVA RECEIVES EUROPEAN COMMISSION APPROVAL FOR RATIOPHARM ACQUISITION ecapproval030810.htm 6-K 52396
2 TEVA RECEIVES EUROPEAN COMMISSION APPROVAL FOR RATIOPHARM ACQUISITION ecapproval030810.pdf 6-K 37002
4 GRAPHIC image001.jpg GRAPHIC 3735
  Complete submission text file 0000818686-10-000086.txt   110324
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 10989505
SIC: 2834 Pharmaceutical Preparations